glp 1 receptor agonists tablets GLP-1 for Type 2 Diabetes: Are They Right for You? FDA approves Foundayo, an oral

Val8-glucagon-like peptide-1 protects against A140-induced impairment of hippocampal late-phase long-term potentiation and spatial learning in rats

Camilleri M, Parkman HP, Shafi MA, Abell TL, Gerson L

Due to the dramatic benefits observed with these medications, barely a day goes by without health care providers and consumer-aimed headlines either raving or raising concerns about them

Fertil Steril 2017;107(4):833839

GLP-1 treatments for weight loss are typically injected at home once daily or weekly, meaning that portability is even less critical unless users are travelling

In obesity treatment, the hierarchy of outcomes is reversed